Results 11 to 20 of about 309,460 (288)

Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management

Frontiers in Medicine, 2022
In recent years, immunotherapy has become an important pillar of cancer treatment, with high response rates regardless of tumor histology or baseline mutations, sometime in patients without any alternative of treatment.
Virginia Robles-Alonso, Fernando Martínez-Valle, Natalia Borruel, Natalia Borruel   +3 more
doaj   +1 more source

Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis. [PDF]

, 2008
PURPOSE: To determine whether simvastatin is able to inhibit inflammation in trinitrobenzene sulfonic acid (TNBS)-induced or oxazalone (OXA)-induced colitis.
Mizuta, Yohei, Kohno, Shigeru, Isomoto, Hajime, Ikeda, Maho, Takeshima, Fuminao, Shikuwa, Saburo, Ozono, Yoshiyuki   +6 more
core   +1 more source

When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest

BMC Medical Ethics, 2019
Background Much like academic-industry partnerships, industry financial support of patient advocacy organizations (PAOs) has become very common in recent years.
Orna Ehrlich, Laura Wingate, Caren Heller, Inmaculada de Melo-Martin   +3 more
doaj   +1 more source

Development of Mucosal PNAd⁺ and MAdCAM-1⁺ Venules during Disease Course in Ulcerative Colitis

Cells, 2020
PNAd and MAdCAM-1 addressins on venules are of importance in T-cell homing and potential therapeutic targets in ulcerative colitis (UC). Normally, PNAd+ high endothelial venules (HEVs) are only present in lymphoid organs, whereas small numbers of MAdCAM ...
Britt Roosenboom, Ellen G. van Lochem, Jos Meijer, Carolijn Smids, Stefan Nierkens, Eelco C. Brand, Liselot W. van Erp, Larissa G.J.M. Kemperman, Marcel J.M. Groenen, Carmen S. Horjus Talabur Horje, Peter J. Wahab   +10 more
doaj   +1 more source

Microscopic colitis: Current status, present and future challenges Statements of the European Microscopic Colitis Group [PDF]

, 2012
Microscopic colitis (MC) is an inflammatory bowel disease presenting with chronic, non-bloody watery diarrhoea and few or no endoscopic abnormalities.
Bonderup, Ole Kristian, Hjortswang, H., Miehlke, S., Ström, M, Hjortswang, H.,, Aust, D., Münch, A., Fernández Bañares, F, Munck, L K, Tysk, C.,, Bonderup, O.,, Bohr, Johan,, Hjortswang, H, Münch, A.,, Tysk, C., Madisch, A.,, Bañares, F. Fernández,, Bonderup, O., Münch, A, Miehlke, S, Aust, D.,, Madisch, A., Aust, D, Ström, M.,, Hjortswang, Henrik,, Ström, M., Madisch, A, Miehlke, S.,, Fernandez Banares, F.,, Munck, L.K., Bohr, J.,, Ström, Magnus,, Munck, L. K.,, Bohr, Jakob, Münch, Andreas,, Tysk, Curt,, Tysk, C, Bohr, J., Fernández Bañares, F.   +38 more
core   +1 more source

Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice [PDF]

, 2012
Background/Aims: Compounds of Cannabis sativa are known to exert anti-inflammatory properties, some of them without inducing psychotropic side effects. Cannabidiol (CBD) is such a side effect-free phytocannabinoid that improves chemically induced colitis
Martin Storr, Storr, Martin, Rudolf Schicho, Schicho, Rudolf   +3 more
core   +1 more source

COLITIS. [PDF]

The Lancet, 1895
n ...
openaire   +1 more source

Use of new, once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis. Is there anything new under the sun? [PDF]

, 2009
5-aminosalicylate (5-ASA) agents remain the mainstay treatment in ulcerative colitis (UC). A number of oral 5-ASA agents are commercially available, including azobond pro-drugs, as well as delayed- and controlled-release forms of mesalazine.
Lakatos, Péter László
core   +1 more source

Eosinophilic colitis

World Journal of Gastroenterology, 2009
Eosinophilic colitis (EC) is a rare form of primary eosinophilic gastrointestinal disease with a bimodal peak of prevalence in neonates and young adults. EC remains a little understood condition in contrast to the increasingly recognized eosinophilic esophagitis.
Okpara, Nnenna, Aswad, Bassam, Baffy, Gyorgy   +2 more
openaire   +4 more sources

The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe

BMC Gastroenterology, 2021
Background Ulcerative colitis (UC) is an inflammatory bowel disease with increasing prevalence worldwide. Current treatment strategies place considerable economic and humanistic burdens on patients.
Leonardo Ruiz-Casas, Jonathan Evans, Alison Rose, Gabriel Ghizzi Pedra, Alan Lobo, Alan Finnegan, Bu Hayee, Laurent Peyrin-Biroulet, Andreas Sturm, Johan Burisch, Helen Terry, Luisa Avendano, Seb Tucknott, Gionata Fiorino, Jimmy Limdi   +14 more
doaj   +1 more source